ELRIG Drug Discovery 2026 has ended. This guide stays up as the record of who was there. Next: ELRIG DD 2027, Oct 19–20, 2027 in Liverpool

Assays, screening and sample management at ELRIG Drug Discovery 2026

Oct 14–15, 2026 London, UK ~3k attendees Website

106 organizations at ELRIG Drug Discovery 2026 present work in assays, screening and samples: 99 technology and service providers, 4 academic, government and non-profit bodies and 3 drug developers. Between them they bring 44 presentations to the program. Most represented: AstraZeneca, Pharmaron and Wellcome Sanger Institute. As of Oct 8, 2026.

All 388 organizations at ELRIG Drug Discovery 2026 →

Showing 1–11 of 106 organizations

Organization	ELRIG Drug Discovery 2026 Attendance
AstraZeneca Cambridge, UK	◆Partner
astrazeneca.com Large pharmaPartner Global biopharmaceutical company discovering and developing medicines in oncology, rare disease, and cardiovascular, renal, metabolic and respiratory disease.	Booth Exhibiting at Booth CZ01 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - CRISPR/Cas technologies from discovery to therapeutic application How CRISPR gene editing is used from finding drug targets to engineering cell and gene therapies, and where it may go next. Tech Theatre with The Francis Crick Institute Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with Domainex Talk Wed Oct 14 11:20am–11:50am From Design Space to Data Space: An AI-Driven Approach to Better Cell Models and Smarter Assays Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery Talk Wed Oct 14 11:50am–12:20pm Automating In Vivo Antibody Discovery How a manual B-cell processing workflow was automated to reduce operator variability and raise throughput while preserving cell quality. Exhibition Hall Theatre with Hamilton Talk Wed Oct 14 12:20pm–12:50pm Finding Small Molecule Tools in Compound Pools using Surface Plasmon Resonance Auditorium 4 Next-gen biophysics Talk Wed Oct 14 2:40pm–3:10pm Transforming Targeted Therapeutics: Innovation in ADC Bioconjugation and Radioligands Auditorium 3 Targeted potency: Advances in radioligands and bioconjugates Talk Wed Oct 14 3:10pm–3:45pm To PhD or not to PhD? Navigating Life Sciences careers as an ECP Whether early career scientists gain more from a doctorate or from hands-on experience, and how people actually build life science careers. Learning Zone Panel Wed Oct 14 4:30pm–5:00pm Panel session - The Future of AI and Design of Experiments in Drug Discovery Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery · with Cambridge Consultants, IQVIA Talk Wed Oct 14 4:30pm–5:00pm Rewriting Disease-Causing Variants: Templated Editing In Vivo Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 12:40pm–1:10pm The AstraZeneca Global Cell Bank: Powering Consistent and Compliant Drug Discovery Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery Talk Thu Oct 15 3:30pm–4:00pm (AI)straZeneca: Case Studies in the Integration of Machine Learning and Medicinal Chemistry Auditorium 3 AI in medicinal chemistry
Pharmaron Beijing, China	◆Conference Partner
pharmaron.com CROs & CDMOsConference Partner Contract research, development and manufacturing provider covering small molecules, biologics and cell and gene therapy, with integrated discovery teams from hit to candidate.	Booth Exhibiting at Booth D12, D13 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Thu Oct 15 10:50am–10:55am Track Chair - AI in medicinal chemistry How AI and machine learning are changing drug discovery, covering compound quality, links to lab validation and newer AI tools. Auditorium 3 with IUPAC, Royal Society of Chemistry Talk Thu Oct 15 11:25am–11:55am A CNS‑Focused Approach to Selective PARP1 Drug Discovery How chemists designed a selective, brain-penetrant oral inhibitor for brain cancers, aiming to avoid the blood toxicities that limit older drugs. Exhibition Hall Theatre
Wellcome Sanger Institute Hinxton, UK
sanger.ac.uk Academic & healthcare Genomics research institute near Cambridge, UK.	Talk Wed Oct 14 2:00pm–2:30pm A CRISPR way to understand neurodegeneration Tech Theatre CRISPR/Cas technologies from discovery to therapeutic application Talk Thu Oct 15 10:55am–11:25am Building a tumour-derived organoid biobank: logistics and technology for multi-omic and functional screening at scale Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery
Domainex Cambridge, UK
domainex.co.uk CROs & CDMOs Integrated drug discovery services partner covering target expression, hit identification and lead optimisation through to preclinical candidates.	Booth Exhibiting at Booth J34 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Wed Oct 14 11:15am–11:20am Track Chair - Next-gen biophysics How biophysics has shaped drug discovery from checking targets to refining lead compounds, and how newer methods can speed programmes up. Auditorium 4 with AstraZeneca Talk Wed Oct 14 2:30pm–2:35pm Technology Spotlight Exhibition Hall Theatre Translating ideas into therapies - Navigating the challenges
Medicines Discovery Catapult Alderley Park, UK
md.catapult.org.uk Gov/NGO UK national centre helping drug discovery entrepreneurs validate ideas and de-risk investment through its expertise, technology and national programmes.	Booth Exhibiting at Booth G28 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 4:15pm–4:30pm Advancing Drug Discovery Through Radiopharmaceutical Innovation Why radioactive drugs that both image and treat tumours can confirm a drug reaches its target, and what manufacturing hurdles remain. Auditorium 3 Talk Thu Oct 15 2:30pm–3:00pm Mind the Gap: Maximising Sample Value from Collection to Translation - A new route to unlock the translational potential of human biological samples Auditorium 4 From sample to translation: Solving the practical challenges of modern drug discovery
WuXi AppTec Shanghai, China	◆Conference Partner
wuxiapptec.com CROs & CDMOsConference Partner Global CRDMO providing integrated research, development and manufacturing services to pharma and biotech across Asia, Europe and North America.	Booth Exhibiting at Booth H03, H10 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 11:50am–12:20pm Integrated Discovery of Targeted Delivery Ligands for Oligonucleotide Therapeutics Finding ring-shaped peptides that bind receptors on brain and muscle cells and carry attached siRNA into them to silence target genes. Auditorium 3 Talk Wed Oct 14 2:30pm–2:40pm Technology Spotlight Auditorium 3 Targeted potency: Advances in radioligands and bioconjugates
Axxam Milan, Italy	◆Conference Partner
axxam.com CROs & CDMOsConference Partner Contract research organisation offering integrated early discovery, from AI-supported target identification and validation through hit finding to hit-to-lead, with compound collections.	Booth Exhibiting at Booth G06, G07 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Thu Oct 15 11:25am–11:55am From Gene Perturbation to Phenotype: Integrating Cell Painting and Transcriptomics in Human iPSC-Derived Motor Neurons Auditorium 2 The power of imaging in drug discovery and the clinic
Carterra Salt Lake City, Utah	◆Conference Partner
carterra-bio.com Instruments & automationConference Partner Makes high-throughput SPR platforms (LSA, LSA-XT, Ultra, Vega) for label-free screening and characterisation of large and small molecules.	Booth Exhibiting at Booth G08 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 11:50am–12:20pm HT-SPR Technology as a Data Engine for AI-Driven Drug Design How high-throughput surface plasmon resonance binding measurements can generate the large, consistent datasets that train AI models for drug design. Auditorium 4
Cenevo	◆Conference Partner
cenevo.com Software & AIConference Partner Lab software combining Mosaic sample management with Labguru inventory, registration, ELN and LIMS, plus automation, orchestration and AI tools.	Booth Exhibiting at Booth D03 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Thu Oct 15 11:25am–11:55am Rethinking Sample Management in the Age of AI How lab sample management systems must change so AI agents can query sample data and start work across connected lab tools. Auditorium 3
Nuclera Cambridge, UK	◆Conference Partner
nuclera.com Instruments & automationConference Partner eProtein Discovery benchtop system pairing cell-free expression with digital microfluidics to screen and produce proteins within two days.	Booth Exhibiting at Booth H04, H09 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Talk Wed Oct 14 11:50am–12:20pm Closing the AI Antibody DBTL Loop with Cell-Free Screening Auditorium 2 Integrating experimental design, lab-in-the-loop and AI towards translatable discovery
SLAS Oak Brook, IL	◆Partner
slas.org Gov/NGOPartner Global society of more than 24,000 scientists and technology providers focused on laboratory automation and screening.	Booth Exhibiting at Booth C17 Wed, Oct 148:00am–7:00pmThu, Oct 158:00am–4:00pm Chair Thu Oct 15 10:50am–10:55am Track Chair - From sample to translation: Solving the practical challenges of modern drug discovery How laboratories source, store and handle biological samples, and why that work shapes data quality and whether findings reach patients. Auditorium 4